Print 
Share 
Text 
To reset, hold the Ctrl key, then press 0.
Marina Moraitis (second from left) joined more than 2,000 other tartan-clad runners in Perth’s World Record Kilt Run in June 2017. Fellow kilt-runners included (left to right) Susan Sami, Georgette Houle and Hayley Claassen. Photo by Ian Hunter.
Marina Moraitis has a collection of “bling” – medals she’s won from running road races. Her collection includes a dog tag from the 2017 Army Run and a medal from the 2012 Ottawa Race Weekend Half-Marathon. There’s one medal, however, for a cause very close to her heart. It’s from the 2010 Run for the Cure 5 km, which she trained for while undergoing chemotherapy for breast cancer.
The results of Moraitis’ lumpectomy showed she had infiltrating ductile carcinoma, high grade, stage 2. She had the BRCA1 gene mutation. Because she was at high risk of her cancer spreading, she had a double mastectomy followed by an oophorectomy to remove her ovaries.
During her treatment Moraitis joined two clinical trials run through The Ottawa Hospital. As part of the first trial, she ran three times a week on a treadmill.
Breast cancer patients ran on treadmills during a clinical trial to help determine the importance of cardiovascular exercise while undergoing cancer therapy.
“The idea was to see if exercise helps cancer patients during chemo. It was proven as extremely beneficial,” said Moraitis. “It not only kept me in shape during my treatment, it also helped me focus on training for the 5km Run for the Cure – my goal at the end of the treatment.”
Led by The Ottawa Hospital’s Dr. Roanne Segal, the treadmill-study results showed that patients with breast cancer who did an hour of cardiovascular exercise three times a week felt the best, and Moraitis fit into that category.
The second trial was Dr. Barb Collins’ that looked at the effects of chemotherapy on patients’ brains.
Cancer patients have long claimed that chemotherapy was affecting the way they think. It was like they were in a fog, not thinking clearly – an unproven condition dubbed ‘chemo fog.’
The Ottawa Hospital led the way in being one of the first in the world to do a pre-and-post study of the effects of chemotherapy on the brain. Since then, it has become a huge area of research for different kinds of cancer treatment.
MRIs of patients’ brains, like this one, help determine ‘chemo fog.’
Dr. Collins and her colleagues designed a clinical trial to look at patients before, during and after chemotherapy. Twenty trial participants underwent magnetic resonance imaging (MRI) studies where brain activity was observed while they responded to cognitive questions.
“In the women who received chemotherapy, you could see differences in the patterns of brain activation in the MRI even when they performed perfectly normally on the test. In simplistic terms, the brain is working harder,” said Dr. Collins. “As a result of studies like this one, championed at The Ottawa Hospital, chemo fog is now taken more seriously.”
Marina Moraitis skied on Christmas Eve day 2017 by the Rideau River. Photo by Gina Watson.
Staff at the Breast Health Centre introduced Moraitis to the support group Breast Cancer Action, where she met several other breast cancer survivors. Relationships began to blossom and the women often went for coffee after their exercise class. They became close friends and formed a book club that continues to meet once a month.
Moraitis felt very supported by the programs and staff at The Ottawa Hospital and was inspired to give back, to help future patients have a better chance of survival.
“Without the hospital, I would not have this sisterhood today, which is so important to me. I owe so much to The Ottawa Hospital,” she said. “Participating in the clinical trials was my small way of helping future patients through research and treatments and saying thank you. The support I received was immeasurable – psychologically, physically, and emotionally.”
The Ottawa Hospital is raising funds for cancer research. Your ongoing support is needed to purchase equipment and fund research. Innovative cancer research takes more than the best minds – our researchers need the proper tools to do their vital work.
Support patient care and research at
The Ottawa Hospital
You might also like…
Mental health professionals and paramedics team up to help people in crisis
Seven days a week, a mental health professional from The Ottawa Hospital hits the road with a paramedic from the Ottawa Paramedic Service. Together, they respond to 911 calls for mental health emergencies across the city. Social worker Cindy Gill and paramedic Scott Farrell share how the Mental Wellbeing Response Team provides quality care for patients out in the community.
A team from The Ottawa Hospital helps organize first-ever oncology conference in the North
When it comes to cancer treatment, there’s no place like home. This spring, a team from The Ottawa Hospital helped organize Nunavut’s first-ever oncology conference to figure out how to bring oncology care closer to home for patients.
“Stewards of hormones”: Our Gender Diversity Specialty Clinic guides medically complex patients on their affirmation journey
Often, trans and non-binary patients struggle to find health-care providers to support them on their affirmation journey. It is even more difficult for patients with complex medical needs. That’s why we launched our Gender Diversity Specialty Clinic, one of the first of its kind in Canada.
The comfort of home: Home Dialysis Program empowers patients to live more independent lives
For people living with kidney failure, the most ideal form of dialysis treatment is done in the place where they are most comfortable—their home. Five years ago, we transformed our Home Dialysis Program, enhancing quality of life for our patients, welcoming more patients, and turning it into a model for dialysis programs across the province.
New Research Chair in Gay Men’s Health is setting out to break down barriers to care
As both a researcher and a gay man, Dr. Paul MacPherson knows all too well the stigma that gay men often face in the health-care system. Now, as the Clinical Research Chair in Gay Men’s Health at The Ottawa Hospital and the University of Ottawa, he’s on a mission to make quality health care more accessible to this often overlooked patient population.
The Ottawa Hospital administers world-first in-utero treatment for rare genetic disorder
Before Ayla was born, she had already made history. Last year at The Ottawa Hospital, she received a world-first in-utero treatment for Pompe disease, a rare genetic disorder that had taken the lives of two of her siblings. Now 17 months old, Ayla is healthy and happy.
Comment on this post